Drug R&D
GI-1606
Eduardo
Sobarzo Sánchez
Publications by the researcher in collaboration with Eduardo Sobarzo Sánchez (17)
2019
-
Aporphines and Alzheimer's Disease: Towards a Medical Approach Facing the Future
Current medicinal chemistry, Vol. 26, Núm. 18, pp. 3253-3259
-
In silico prediction of P-glycoprotein binding: Insights from molecular docking studies
Current Medicinal Chemistry, Vol. 26, Núm. 10, pp. 1746-1760
-
Potent in Vitro α-Glucosidase Inhibition of Secondary Metabolites Derived from Dryopteris cycadina
Molecules, Vol. 24, Núm. 3
-
Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: Targeting neurological and mental disorders
Molecules, Vol. 24, Núm. 3
2018
-
Ligand and structure-based modeling of passive diffusion through the blood-brain barrier
Current Medicinal Chemistry, Vol. 25, Núm. 9, pp. 1073-1089
-
Nanomedicine and Parkinson’s disease: A nanoparticle medical approach
Psychiatric and Mood Diseases and the Natural Compounds: An Approach to the Future Medical Tool (Nova Science Publishers, Inc.), pp. 153-168
2017
-
A medical approach to the monoamine oxidase inhibition by using 7H-benzo[e]perimidin-7-one derivatives
Current Topics in Medicinal Chemistry, Vol. 17, Núm. 7
-
Aporphine alkaloids and their antioxidant medical application: From antineoplastic agents to motor dysfunction diseases
Current Organic Chemistry, Vol. 21, Núm. 4, pp. 342-347
-
Molecular docking and drug discovery in β-adrenergic receptors
Current Medicinal Chemistry, Vol. 24, Núm. 39, pp. 4340-4359
2016
-
Aporphines and parkinson’s disease: Medical tools for the future
Current Topics in Medicinal Chemistry, Vol. 16, Núm. 17, pp. 1906-1909
2015
-
Anxiolytic-like effects of 7H-benzo[e]perimidin-7-one derivatives through elevated plus-maze test in mice
Current Topics in Medicinal Chemistry, Vol. 15, Núm. 17, pp. 1750-1754
-
Nanoparticles in the treatment of mental disorders: A new tool in the psychiatric medication
Current Topics in Medicinal Chemistry, Vol. 15, Núm. 4, pp. 282-286
2014
-
Comparison of the antidepressive effects of trans-resveratrol and 5-methoxy-7H-dibenzo[de,h]quinolin-7-one.
Current topics in medicinal chemistry, Vol. 14, Núm. 2, pp. 234-238
2013
-
Host-guest interaction between new nitrooxoisoaporphine and β-cyclodextrins: Synthesis, electrochemical, electron spin resonance and molecular modeling studies
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy, Vol. 102, pp. 226-234
-
Synthetic oxoisoaporphine alkaloids: in vitro, in vivo and in silico assessment of antileishmanial activities.
PloS one, Vol. 8, Núm. 10
2012
-
Monoamino oxidase A: An interesting pharmacological target for the development of multi-target QSAR
Mini-Reviews in Medicinal Chemistry, Vol. 12, Núm. 10, pp. 947-958
2010
-
New approaches to 6-oxoisoaporphine and tetrahydroisoquinoline derivatives
Helvetica Chimica Acta, Vol. 93, Núm. 7, pp. 1385-1394